{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:27:33Z","timestamp":1770892053967,"version":"3.50.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R278-2018-180"],"award-info":[{"award-number":["R278-2018-180"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008392","name":"Danmarks Frie Forskningsfond Sundhed og Sygdom","doi-asserted-by":"publisher","award":["3122-00044B"],"award-info":[{"award-number":["3122-00044B"]}],"id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF21OC0070347"],"award-info":[{"award-number":["NNF21OC0070347"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.metabol.2025.156489","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:01:36Z","timestamp":1767916896000},"page":"156489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Global glucagon-like peptide-2 receptor activation linked to increased obesity risk in the UK Biobank"],"prefix":"10.1016","volume":"177","author":[{"given":"Peter A.","family":"Gerlach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarina","family":"Gadgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob S.","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier Sanchez","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Faas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria B.N.","family":"Gabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette M.","family":"Rosenkilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander S.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.metabol.2025.156489_bb0005","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","article-title":"The global burden of metabolic disease: data from 2000 to 2019","volume":"35","author":"Chew","year":"2023","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.metabol.2025.156489_bb0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-021-00337-8","article-title":"Anti-obesity drug discovery: advances and challenges","volume":"21","author":"M\u00fcller","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"D1","key":"10.1016\/j.metabol.2025.156489_bb0015","doi-asserted-by":"crossref","first-page":"D1486","DOI":"10.1093\/nar\/gkae1127","article-title":"PGxDB: an interactive web-platform for pharmacogenomics research","volume":"53","author":"Nguyen","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.metabol.2025.156489_bb0020","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/10408363.2024.2358304","article-title":"G protein-coupled receptor (GPCR) pharmacogenomics","volume":"61","author":"Thompson","year":"2024","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"5","key":"10.1016\/j.metabol.2025.156489_bb0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10408363.2023.2286606","article-title":"G protein-coupled receptor (GPCR) gene variants and human genetic disease","volume":"61","author":"Thompson","year":"2024","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"2","key":"10.1016\/j.metabol.2025.156489_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101413","article-title":"Molecular and in vivo phenotyping of missense variants of the human glucagon receptor","volume":"298","author":"van der Velden","year":"2022","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.metabol.2025.156489_bb0035","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s42255-023-00889-6","article-title":"Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity","volume":"5","author":"Gao","year":"2023","journal-title":"Nat Metab"},{"issue":"6","key":"10.1016\/j.metabol.2025.156489_bb0040","first-page":"1","article-title":"Characterization of genetic variants of GIPR reveals a contribution of \u03b2-arrestin to metabolic phenotypes","volume":"2024","author":"Kizilkaya","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.metabol.2025.156489_bb0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2019.03.044","article-title":"Human gain-of-function MC4R variants show signaling Bias and protect against obesity","volume":"177","author":"Lotta","year":"2019","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.metabol.2025.156489_bb0050","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41588-023-01462-3","article-title":"GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification","volume":"55","author":"Lagou","year":"2023","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.metabol.2025.156489_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0016-5085(99)70555-X","article-title":"Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans","volume":"117","author":"Xiao","year":"1999","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.metabol.2025.156489_bb0060","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1111\/bph.15866","article-title":"N-terminal alterations turn the gut hormone GLP-2 into an antagonist with gradual loss of GLP-2 receptor selectivity towards more GLP-1 receptor interaction","volume":"179","author":"Gabe","year":"2022","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1016\/j.metabol.2025.156489_bb0065","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nbt0797-673","article-title":"Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV","volume":"15","author":"Drucker","year":"1997","journal-title":"Nat Biotechnol"},{"issue":"8","key":"10.1016\/j.metabol.2025.156489_bb0070","first-page":"2884","article-title":"In vivo and in vitro degradation of glucagon-like Peptide-2 in humans","volume":"85","author":"Hartmann","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.metabol.2025.156489_bb0075","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/bph.15766","article-title":"Novel agonist and antagonist radioligands for the GLP-2 receptor. Useful tools for studies of basic GLP-2 receptor pharmacology","volume":"179","author":"Gadgaard","year":"2022","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.metabol.2025.156489_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-49510-5","article-title":"The roles of glucagon-like peptide-2 and the intestinal epithelial insulin-like growth factor-1 receptor in regulating microvillus length","volume":"9","author":"Markovic","year":"2019","journal-title":"Sci Rep"},{"issue":"15","key":"10.1016\/j.metabol.2025.156489_bb0085","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1073\/pnas.93.15.7911","article-title":"Induction of intestinal epithelial proliferation by glucagon-like peptide 2","volume":"93","author":"Drucker","year":"1996","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.metabol.2025.156489_bb0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/bj20020393","article-title":"Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2","volume":"367","author":"Au","year":"2002","journal-title":"Biochem J"},{"issue":"1\u20133","key":"10.1016\/j.metabol.2025.156489_bb0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.regpep.2011.03.003","article-title":"The effect of glucagon-like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients","volume":"168","author":"Bremholm","year":"2011","journal-title":"Regul Pept"},{"issue":"3","key":"10.1016\/j.metabol.2025.156489_bb0100","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/j.gastro.2009.05.051","article-title":"Glucagon-like Peptide-2 increases intestinal lipid absorption and chylomicron production via CD36","volume":"137","author":"Hsieh","year":"2009","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.metabol.2025.156489_bb0105","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1053\/j.gastro.2014.08.037","article-title":"Glucagon-like Peptide-2 regulates release of chylomicrons from the intestine","volume":"147","author":"Dash","year":"2014","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.metabol.2025.156489_bb0110","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1152\/ajpendo.00245.2012","article-title":"GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility","volume":"303","author":"Guan","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2025.156489_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2016.09.010","article-title":"Influence of glucagon-like peptide 2 on energy homeostasis","volume":"86","author":"Baldassano","year":"2016","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/j.metabol.2025.156489_bb0120","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.gassur.2024.04.009","article-title":"Efficacy and safety of glucagon-like peptide 2 in patients with short bowel syndrome: a systematic review and network meta-analysis","volume":"28","author":"Sabra","year":"2024","journal-title":"J Gastrointest Surg"},{"issue":"13","key":"10.1016\/j.metabol.2025.156489_bb0125","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/bph.16040","article-title":"Biased GLP-2 agonist with strong G protein-coupling but impaired arrestin recruitment and receptor desensitization enhances intestinal growth in mice","volume":"180","author":"Gabe","year":"2023","journal-title":"Br J Pharmacol"},{"issue":"6 35-6","key":"10.1016\/j.metabol.2025.156489_bb0130","article-title":"Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2","volume":"272","author":"Brubaker","year":"1997","journal-title":"The American Journal of Physiology"},{"issue":"7","key":"10.1016\/j.metabol.2025.156489_bb0135","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/77535","article-title":"The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake","volume":"6","author":"Tang-Christensen","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2025.156489_bb0140","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/sj.ijo.0801912","article-title":"Glucagon-like peptide containing pathways in the regulation of feeding behaviour","volume":"25","author":"Tang-Christensen","year":"2001","journal-title":"Int J Obes"},{"issue":"24","key":"10.1016\/j.metabol.2025.156489_bb0145","doi-asserted-by":"crossref","first-page":"21489","DOI":"10.1074\/jbc.M009382200","article-title":"Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling","volume":"276","author":"Lovshin","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2025.156489_bb0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1530\/JOE-16-0035","article-title":"GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity","volume":"229","author":"Amato","year":"2016","journal-title":"J Endocrinol"},{"issue":"6","key":"10.1016\/j.metabol.2025.156489_bb0155","doi-asserted-by":"crossref","first-page":"R585","DOI":"10.1152\/ajpregu.00096.2014","article-title":"The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis","volume":"307","author":"Guan","year":"2014","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"10.1016\/j.metabol.2025.156489_bb0160","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1021\/acsptsci.0c00193","article-title":"GLP-1 Val8: a biased GLP-1R agonist with altered binding kinetics and impaired release of pancreatic hormones in rats","volume":"4","author":"Van Der Velden","year":"2021","journal-title":"ACS Pharmacology and Translational Science"},{"issue":"14","key":"10.1016\/j.metabol.2025.156489_bb0165","doi-asserted-by":"crossref","first-page":"10576","DOI":"10.1074\/jbc.M609695200","article-title":"Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate\/G13 pathway","volume":"282","author":"Jiang","year":"2007","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.metabol.2025.156489_bb0170","doi-asserted-by":"crossref","first-page":"2.14.1","DOI":"10.1002\/0471141755.ph0214s70","article-title":"Using bioluminescence resonance energy transfer (BRET) to characterize agonist-induced Arrestin recruitment to modified and unmodified G protein-coupled receptors","volume":"70","author":"Donthamsetti","year":"2015","journal-title":"Current Protocols in Pharmacology"},{"issue":"22","key":"10.1016\/j.metabol.2025.156489_bb0175","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","article-title":"Robust relationship inference in genome-wide association studies","volume":"26","author":"Manichaikul","year":"2010","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.metabol.2025.156489_bb0180","first-page":"1097","article-title":"Computationally efficient whole-genome regression for quantitative and binary traits","volume":"53","author":"Mbatchou","year":"2021","journal-title":"Nature Genetics 2021 53:7"},{"issue":"7886","key":"10.1016\/j.metabol.2025.156489_bb0185","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","article-title":"Exome sequencing and analysis of 454,787 UK biobank participants","volume":"599","author":"Backman","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2025.156489_bb0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ije\/dyx204","article-title":"Software application profile software application profile: PHESANT: a tool for performing automated phenome scans in UK biobank","volume":"47","author":"Millard","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.metabol.2025.156489_bb0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajhg.2021.11.008","article-title":"Portability of 245 polygenic scores when derived from the UK biobank and applied to 9 ancestry groups from the same cohort","volume":"109","author":"Priv\u00e9","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.metabol.2025.156489_bb0200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B Methodol"},{"key":"10.1016\/j.metabol.2025.156489_bb0205","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2023"},{"issue":"1","key":"10.1016\/j.metabol.2025.156489_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"issue":"6664","key":"10.1016\/j.metabol.2025.156489_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.metabol.2025.156489_bb0220","first-page":"186","article-title":"The data model concept in statistical mapping","volume":"7","author":"Jenks","year":"1967","journal-title":"International Yearbook of Cartography"},{"key":"10.1016\/j.metabol.2025.156489_bb0225","series-title":"classInt: Choose Univariate Class Intervals","author":"Bivand","year":"2023"},{"issue":"7","key":"10.1016\/j.metabol.2025.156489_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003153","article-title":"GEMINI: integrative exploration of genetic variation and genome annotations","volume":"9","author":"Paila","year":"2013","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"10.1016\/j.metabol.2025.156489_bb0235","first-page":"54","article-title":"A cross-platform approach identifies genetic regulators of human metabolism and health","volume":"53","author":"Lotta","year":"2021","journal-title":"Nature Genetics 2021 53:1"},{"issue":"6","key":"10.1016\/j.metabol.2025.156489_bb0240","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.ajhg.2022.04.006","article-title":"TOP-LD: a tool to explore linkage disequilibrium with TOPMed whole-genome sequence data","volume":"109","author":"Huang","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.metabol.2025.156489_bb0245","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ajhg.2013.06.020","article-title":"RFMix: a discriminative modeling approach for rapid and robust local-ancestry inference","volume":"93","author":"Maples","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.metabol.2025.156489_bb0250","doi-asserted-by":"crossref","first-page":"G413","DOI":"10.1152\/ajpgi.00435.2012","article-title":"Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients","volume":"304","author":"Sonne","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"8","key":"10.1016\/j.metabol.2025.156489_bb0255","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/jbmr.4308","article-title":"The Antiresorptive effect of GIP, but not GLP-2, is preserved in patients with hypoparathyroidism\u2014a randomized crossover study","volume":"36","author":"Skov-Jeppesen","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2025.156489_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115230","article-title":"Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity","volume":"133","author":"Fuglsang-Nielsen","year":"2020","journal-title":"Bone"},{"issue":"D1","key":"10.1016\/j.metabol.2025.156489_bb0265","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gky1016","article-title":"CADD: predicting the deleteriousness of variants throughout the human genome","volume":"47","author":"Rentzsch","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.metabol.2025.156489_bb0270","article-title":"A small molecule stabilizer rescues the surface expression of nearly all missense variants in a GPCR","volume":"1\u201312","author":"Mighell","year":"2025","journal-title":"Nat Struct Mol Biol"},{"issue":"Volume 76, 2014","key":"10.1016\/j.metabol.2025.156489_bb0275","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1146\/annurev-physiol-021113-170317","article-title":"Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2","volume":"76","author":"Drucker","year":"2014","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"10.1016\/j.metabol.2025.156489_bb0280","first-page":"7973","article-title":"Genomics and phenomics of body mass index reveals a complex disease network. Nature","volume":"13","author":"Huang","year":"2022","journal-title":"Communications"},{"issue":"11","key":"10.1016\/j.metabol.2025.156489_bb0285","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.2337\/db16-1253","article-title":"An expanded genome-wide association study of type 2 diabetes in Europeans","volume":"66","author":"Scott","year":"2017","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.metabol.2025.156489_bb0290","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41576-021-00414-z","article-title":"The genetics of obesity: from discovery to biology","volume":"23","author":"Loos","year":"2022","journal-title":"Nat Rev Genet"},{"issue":"8003","key":"10.1016\/j.metabol.2025.156489_bb0295","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-024-07019-6","article-title":"Genetic drivers of heterogeneity in type 2 diabetes pathophysiology","volume":"627","author":"Suzuki","year":"2024","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.metabol.2025.156489_bb0300","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bone.2009.07.008","article-title":"Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD","volume":"45","author":"Henriksen","year":"2009","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.metabol.2025.156489_bb0305","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.regpep.2012.11.002","article-title":"Effect of glucagon-like peptide-2 exposure on bone resorption: effectiveness of high concentration versus prolonged exposure","volume":"181","author":"Askov-Hansen","year":"2013","journal-title":"Regul Pept"},{"issue":"FEB","key":"10.1016\/j.metabol.2025.156489_bb0310","article-title":"Gut hormones and their effect on Bone metabolism. Potential drug therapies in future osteoporosis treatment","volume":"10","author":"Schiellerup","year":"2019","journal-title":"Front Endocrinol"},{"issue":"20","key":"10.1016\/j.metabol.2025.156489_bb0315","doi-asserted-by":"crossref","first-page":"17916","DOI":"10.1074\/jbc.M110479200","article-title":"Aspartic acid 564 in the third cytoplasmic loop of the luteinizing hormone\/choriogonadotropin receptor is crucial for phosphorylation-independent interaction with arrestin2","volume":"277","author":"Mukherjee","year":"2002","journal-title":"J Biol Chem"},{"issue":"24","key":"10.1016\/j.metabol.2025.156489_bb0320","doi-asserted-by":"crossref","first-page":"25590","DOI":"10.1074\/jbc.M400363200","article-title":"\u03b2-Arrestin-dependent constitutive internalization of the human chemokine decoy receptor D6","volume":"279","author":"Galliera","year":"2004","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.metabol.2025.156489_bb0325","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.pharmthera.2005.09.008","article-title":"The structural basis of arrestin-mediated regulation of G-protein-coupled receptors","volume":"110","author":"Gurevich","year":"2006","journal-title":"Pharmacol Ther"},{"issue":"S1","key":"10.1016\/j.metabol.2025.156489_bb0330","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1038\/sj.bjp.0707662","article-title":"G-protein-coupled receptor phosphorylation: where, when and by whom","volume":"153","author":"Tobin","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.metabol.2025.156489_bb0335","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/mol.116.107839","article-title":"Phosphorylation of G protein-coupled receptors: from the barcode hypothesis to the flute model","volume":"92","author":"Yang","year":"2017","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.metabol.2025.156489_bb0340","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-0115(01)00316-0","article-title":"The truncated metabolite GLP-2 (3\u201333) interacts with the GLP-2 receptor as a partial agonist","volume":"103","author":"Thulesen","year":"2002","journal-title":"Regul Pept"},{"key":"10.1016\/j.metabol.2025.156489_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2024.171210","article-title":"Targeting the GLP-2 receptor in the management of obesity","volume":"177","author":"P\u00e1lsson","year":"2024","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.metabol.2025.156489_bb0350","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.regpep.2012.10.002","article-title":"Glucagon-like peptide-2 stimulates mucosal microcirculation measured by laser Doppler flowmetry in end-jejunostomy short bowel syndrome patients","volume":"180","author":"H\u00f8yerup","year":"2013","journal-title":"Regul Pept"},{"issue":"9","key":"10.1016\/j.metabol.2025.156489_bb0355","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/nu17091416","article-title":"Glucagon-like Peptide-2 acts partially through central GLP-2R and MC4R in mobilizing stored lipids from the intestine","volume":"17","author":"Mukherjee","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.metabol.2025.156489_bb0360","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/jpet.119.262238","article-title":"Pharmacological characterization of apraglutide, a novel long-acting peptidic glucagon-like peptide-2 agonist, for the treatment of short bowel syndrome","volume":"373","author":"Hargrove","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.metabol.2025.156489_bb0365","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.clnesp.2022.09.552","article-title":"An ongoing phase 2 study of Hm15912, a novel long-acting glucagon-like peptide 2 (Glp-2) analog for short bowel syndrome-intestinal failure (Sbs-if) patients","volume":"54","author":"Kim","year":"2023","journal-title":"Clinical Nutrition ESPEN"},{"key":"10.1016\/j.metabol.2025.156489_bb0370","year":"2024","journal-title":"Clinicaltrials.Gov"},{"key":"10.1016\/j.metabol.2025.156489_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106058","article-title":"GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment","volume":"176","author":"Gabe","year":"2022","journal-title":"Pharmacol Res"},{"issue":"9","key":"10.1016\/j.metabol.2025.156489_bb0380","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41574-024-01000-z","article-title":"Gut hormones and bone homeostasis: potential therapeutic implications","volume":"20","author":"Bouvard","year":"2024","journal-title":"Nature Reviews Endocrinology 2024 20:9"},{"issue":"7","key":"10.1016\/j.metabol.2025.156489_bb0385","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41562-023-01579-9","article-title":"Participation bias in the UK biobank distorts genetic associations and downstream analyses","volume":"7","author":"Schoeler","year":"2023","journal-title":"Nat Hum Behav"},{"issue":"8003","key":"10.1016\/j.metabol.2025.156489_bb0390","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41586-023-06957-x","article-title":"Genomic data in the all of us research program","volume":"627","author":"Bick","year":"2024","journal-title":"Nature"},{"issue":"7762","key":"10.1016\/j.metabol.2025.156489_bb0395","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41586-019-1310-4","article-title":"Genetic analyses of diverse populations improves discovery for complex traits","volume":"570","author":"Wojcik","year":"2019","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.metabol.2025.156489_bb0400","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1210\/en.2004-0100","article-title":"Extrahypothalamic expression of the glucagon-like Peptide-2 receptor is coupled to reduction of glutamate-induced cell death in cultured hippocampal cells","volume":"145","author":"Lovshin","year":"2004","journal-title":"Endocrinology"},{"issue":"1\u20132","key":"10.1016\/j.metabol.2025.156489_bb0405","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2005.12.001","article-title":"Naturally occurring glucagon-like peptide-2 (GLP-2) receptors in human intestinal cell lines","volume":"532","author":"Sams","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"D1","key":"10.1016\/j.metabol.2025.156489_bb0410","doi-asserted-by":"crossref","first-page":"D422","DOI":"10.1093\/nar\/gkt1255","article-title":"GPCRDB: an information system for G protein-coupled receptors","volume":"42","author":"Isberg","year":"2014","journal-title":"Nucleic Acids Res"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525003592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525003592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:37:13Z","timestamp":1770889033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049525003592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":82,"alternative-id":["S0026049525003592"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156489","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global glucagon-like peptide-2 receptor activation linked to increased obesity risk in the UK Biobank","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"156489"}}